Literature DB >> 7449127

Sensitive and specific radioimmunoassay for creatine kinase BB isoenzyme in serum, with use of an autoantibody.

P Urdal, P Kierulf.   

Abstract

We have developed an equilibrium radioimmunoassay for creatine kinase BB (CK-BB) isoenzyme in serum. We used as antibody a CK-BB binding immunoglobulin G isolated from serum of a patient with macro CK-BB. Free and antibody-bound tracer were separated by anion-exchange chromatography. The affinity constant, Keq, for the binding of CK-BB to immunoglobulin was calculated as 1.4 X 10(11) L/mol, which suggests that the immunoglobulin was an autoantibody. The assay may detect 1 microgram of enzyme per liter in a 100- microL sample. CK-MM and CK-MB isoenzymes did not cross react in the assay. Within-assay precision (CV) was 5%; between-assay precision was 14 and 15% at 6 and 14 microgram of CK-BB per liter, respectively. Of 45 sera from blood donors, 95% contained < 1.8 microgram of CK-BB per liter, whereas of 19 sera from unselected patients the corresponding figure was 2.8 microgram/L.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7449127

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  3 in total

1.  Increased serum creatine kinase BB and neuron specific enolase following head injury indicates brain damage.

Authors:  I M Skogseid; H K Nordby; P Urdal; E Paus; F Lilleaas
Journal:  Acta Neurochir (Wien)       Date:  1992       Impact factor: 2.216

2.  A monoclonal antibody to human brain-type creatine kinase. Increased avidity with mercaptans.

Authors:  A P Jackson; K Siddle; R J Thompson
Journal:  Biochem J       Date:  1983-12-01       Impact factor: 3.857

3.  Creatine kinase BB in blood as index of prognosis and effect of treatment after severe head injury.

Authors:  H K Nordby; P Urdal
Journal:  Acta Neurochir (Wien)       Date:  1985       Impact factor: 2.216

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.